A key role of signal transduction pathways is to control transcriptional programs in the nucleus as a function of signals received by the cell via complex post-translational modification cascades. This determines cell-context specific responses to environmental stimuli. Given the difficulty of quantitating protein concentration and post-translational modifications, signaling pathway studies are still for the most part conducted one interaction at the time. Thus, genome-wide, cell-context specific dissection of signaling pathways is still an open challenge in molecular systems biology.
Introduction
A key role of signal transduction pathways is to control transcriptional programs in the nucleus as a function of signals received by the cell via complex posttranslational modification cascades, thus determining the cell's response to environmental stimuli (see Figure S1 for a schematic description). Their understanding is increasingly crucial in the dissection of human disease and in the identification of therapeutic intervention targets [1] , because signaling molecules (e.g., GPCR receptors or tyrosine kinases) are much more effectively targeted by small molecules than transcription factors. Unfortunately, cellcontext specific dissection of signaling pathways is still an open challenge because of the inherent difficulties in the high-throughput measurement of protein concentration and post-translational modification. As a result, the dissection of signaling pathway is still, for the most part, proceeding one protein-protein interaction at a time [2] .
Conversely, availability of large collections of gene expression profiles (GEP) [3] has fostered significant progress in the genome-wide dissection of transcriptional programs [4, 5] . Until recently, GEPs have not been broadly used in the dissection of post-translational interactions. Several GEP-based studies of yeast signal transduction networks have been limited to the identification of gene modules regulated by a small number of regulators, including some signaling proteins [3] , or to the reconstruction of signaling pathways using known protein-protein interactions as a topological backbone [6] . In general, however, a cell-context-specific map of the interface between signaling and transcriptional regulatory programs is still an elusive target both in yeast and in higher eukaryotes.
We recently introduced the MINDy algorithm (Modulator Inference by Network Dynamics) for the genome-wide identification of post-translational modulators of transcription factor (TF) activity [7] . MINDy tests whether the conditional mutual information (CMI), I[TF; t | M ], between a transcription factor TF and a target t, as a function of a modulator M is non-constant. In that case, M is inferred as a candidate post-translational modulator of the TF. Based on this analysis, MINDy can also determine whether the modulator protein will activate or repress the TF-target interaction, resulting in either a positive or negative mode of action (MoA). We have biochemically validated four inferred modulators of the transcription factor MYC, including a kinase (STK38), an histone deacetylase (HDAC1), and two transcription factors (BHLHB2 and MEF2B) by shRNA mediated silencing and other biochemical assays [8] . For full details on the MINDy algorithm, its applications as well as limitations, readers are referred to [7, 8] and the Methods section 5.2. In this manuscript, we extend the MINDy algorithm to the genome-wide exploration of the interface between signaling pathways and transcriptional networks in human B cells.
Results

Network components
In this work we define the signalome as the compendium of signaling proteins (SP) annotated as protein kinases, phosphatases or cell surface receptors in the Gene Ontology (GO) [9] . The term "transfactome" is borrowed from [10] and is defined here as the compendium of proteins annotated as transcription factors (TF) in the GO. Only proteins expressed in a set of 254 GEPs from normal and tumor related human B cells were considered in the analysis (see 5.1). A total of 772 SPs and 595 TFs were selected based on these criteria, see Table 1 . 
Signalome-transfactome interaction inference
SP-TF interactions were inferred by assessing whether one or more TF-target interactions were modulated by the SP using the CMI test (see 5.2). The complete set of TF-targets modulated by a SP is called the SP's regulon, while the set of all TFs modulated by a SP is called the SP's modulon ( Figure S3 ). At the genome-wide statistical significance level of 5% (see 5.2), MINDy inferred 44,349 SP-TF interactions. A summary of these results can be found in Table 2 . Each SP modulates on average 29.6 TFs in human B cells, and a TF is controlled on average by 38.4 SPs. Some other interesting global properties of the signalome-transfactome interface are summarized in Figure 1 (and more are reported in the supplementary materials). These include: (a) The MoA is consistently inferred from each SP-TF-target triplet supporting a specific SP-TF interaction, even though they are independently tested. i.e., either the positive or the negative MoA is supported by the majority (95 -100%) of the triplets. This is highly biologically consistent, since a given SP is expected to either activate or repress a TF's activity but not to do both at the same time. (b) MINDyinferred TF-target interactions exhibits the previously observed scale-free like degree distribution [11] . However, while previously inferred regulatory networks included only static (i.e. not SP-modulated) TF-target interactions, MINDy inferred network includes conditional interactions as well. 
In-silico validation
To benchmark the accuracy of MINDy inferences, a set of gold standard SP-TF interactions in human B cells would be required. Compiling such a reference set is relatively difficult because: (a) experimentally validated protein-protein interactions in databases are still very sparse, especially for transient interactions (e.g., kinase-substrate); (b) MINDy-inferred modulators can be either direct (i.e. a physical SP-TF interaction), or pathway-mediated (i.e. SP upstream of the TF in a signaling pathway). While the former could be represented in existing databases, the latter are poorly characterized; and (c) while MINDy inferred SP-TF interactions are highly cell-context specific (to human B cells), human protein-protein interactions have been validated in highly heterogeneous or even artificial (e.g., yeast two-hybrid, Y2H) cellular contexts. To address (a) and (b) we benchmarked MINDy with the following datasets: Protein-protein interactions (PPIDB): We collected all known human PPIs from high-quality public databases including HPRD [12] , BIND [13] , DIP [14] and IntAct [15] . These have been experimentally assessed, either in single biochemical assays, or by high throughput techniques such as Y2H. Compared to the 772 SPs and 595 TFs analyzed by MINDy, these datasets cover 428 SPs and 141 TFs (i.e., 13.1% of the MINDy search space). Kinase-substrate interactions (KSIDB): We also included kinase-substrate interactions inferred by the experimentally-validated algorithm NetworKIN [16] . This algorithm utilizes information from consensus motifs on the kinase catalytic sites, substrate phosphorylation sites assessed by Mass Spectrometry, as well as cellular context and curated pathways. Such information is completely orthogonal to that used by MINDy (i.e. strictly GEP). Therefore enrichment of their common predictions can be used to assess MINDy's validity, as false positives from the two methods should not be correlated if either of them makes random predictions. Due to the limited number of kinase families for which consensus motifs are known, NeworKIN covers only 74 of 772 MINDy SPs and 240 of 595 MINDy TFs (i.e., 3.9% of the MINDy search space). Table 3 offers a comparative view of MINDy inferred SP-TF interactions as well as those from PPIDB and KSIDB. Due to the higher coverage of GEP, MINDy covers a much larger space (~7-fold) than the other two data sources combined and may thus provide important information for SP-TF interactions that cannot be studied using other methods. We first tested the hypothesis that modulator sets affecting the same TF should be more physically inter-connected than random genes (as they are more likely to cluster within signaling pathways). This was done by counting the number of PPIDB and KSIDB interactions among MINDy-inferred SPs that modulate the same TF, compared to that among the same number of SPs chosen at random. Of 595 tested TFs, 400 (67.2%) show significant enrichment among their inferred modulator SPs by Fisher's Exact Test (FET) (i.e. p-value < 0.05/595). This suggests that SPs modulating the same TF tend to cluster in physical pathways.
Next, we measured the overlap between MINDy-inferred interactions and those in PPIDB and KSIDB. Since interactions predicted by MINDy include both direct and pathway-mediated interactions, we expanded the interactions in our reference databases with additional ones for which a linear chain of PPIDB (undirected) and/or KSIDB (directed) interactions exists between a SP and a TF, as first proposed in [6] . We plotted the precision of MINDy (i.e. percent of MINDy predictions in the extended database) as a function of the MINDy pvalue threshold (i.e. the threshold that controls the MINDy false positive rate). As expected (Figure 2) , MINDy precision and number of predictions respectively increase and decrease as the p-value threshold becomes more stringent. Based on this plot, we selected the inflection point, corresponding to the MINDy p-value of , as an optimal p-value cutoff, resulting in 9,017 inferred interactions. Of these, 3,739 (41.5%) are supported by either direct or pathway-mediated PPI interactions. The probability that such an overlap occurs by chance is by FET. A similar analysis using KEGG [17] and GenMAPP [18] annotated pathways also yielded statistically significant enrichment (results reported in the supplementary materials). These highly significant enrichments suggest that MINDy is able to recapitulate known interactions at the signalome-transfactome interface. 
Experimental validation
Given the exceedingly large set of MINDy prediction space, a systematic experimental validation plan is clearly impractical. Instead, we decided to validate the candidate modulator controlling the largest number of TFs. This is a serine-threonine kinase STK38 [19] that is poorly characterized in the literature, a rather surprising fact since MINDy infers it as a modulator of 303 TFs. We silenced STK38 by lentiviral-vector mediated shRNA expression in the ST486 Burkitt's line, and verified that the STK38 protein level significantly decreased at 60h after transduction (Figure 3a) .
MINDy regulon analysis:
We first tested whether the 1219 TF-targets that were inferred as STK38 modulated via the 303 TFs (the STK38 regulon) were indeed affected by STK38 silencing. Gene Set Enrichment Analysis (GSEA) [20] confirmed a very significant enrichment (
) of the STK38 regulon in genes that were differentially expressed after silencing (Figure 3b) . Moreover, the set of 303 STK38 modulated TFs (the STK38 modulon) was not enriched in differentially expressed genes (Figure 3c) , suggesting that the differential regulation of the STK38-regulon is not mediated by transcriptional activation/repression of the TFs in its modulon, consistent with the MINDy model which is designed to identify post-translational interactions. Modulator comparison: When compared to the GSEA enrichment of the other SP regulons, the STK38 regulon scored 8 th out of 772. Additionally, the most significantly enriched MINDy regulon was that of the SP having the highest overlap with the STK38 regulon (CDC2L5, with 506 common regulon genes out of 1039), further suggesting that STK38 silencing affects the MINDy-inferred STK38 regulon in a highly specific way. Indeed, based on this high overlap, we hypothesize that CDC2L5 is directly downstream of STK38 so that the higher enrichment is justified by a more specific regulon (1039 for CDC2L5 vs. 1219 for STK38). Further experimental data are required to confirm this hypothesis.
STK38-TF interaction validation:
To test MINDy's ability to infer individual SP-TF interactions, we selected 257 TFs in the STK38 modulon with more than 150 STK38 modulated targets. The 150-target threshold was chosen to ensure sufficient statistical power of the GSEA test. We then tested whether the MINDy inferred targets of each TF were enriched in differentially expressed genes after STK38 silencing. The analysis shows that 78 out of 257 target-sets (30%) are significantly enriched at 5% false positive rate, corresponding to a false discovery rate of 16% (i.e. 257×0.05/78). This is a very high percent because (a) STK38 is so pleiotropic that individual TFs may not be affected at all due to combinatorial regulation effects, and (b) modulation was not inferred by MINDy in the ST486 cell line but rather from a collection of 17 distinct B cell phenotypes (see 5.1). Hence, some TF's targets may not be affected because key co-factors, signals, or effectors are missing. Finally, the most likely topology of the interface between SPs and TFs in human B cells, supported by significant physical evidence from both literature and novel biochemical assays, was obtained by mapping the MINDy predictions onto direct interactions in PPIDB and KSIDB, producing a hybrid network depicted in Figure 4 . The connectivity of nodes in this network follows a powerlaw distribution (see Figure 4 inset), suggesting that the network is scale-free. MINDy-inferred signaling interactions supported by KSIDB appear to be more pleiotropic than those supported by PPIDB, perhaps due to the nature of the two evidence sources: NetworKIN makes predictions on well-studied kinases (with known consensus motif), whereas high-throughput PPI measurements in the database, e.g. Y2H, tend to have less selection bias and a high false negative rate. MINDy predicted SP-TF interactions supported by PPIDB or KSIDB (i.e. modulatory interactions predicted by MINDy that have physical interaction evidence); 2) MINDy predicted SP-SP interactions supported by PPIDB or KSIDB (i.e. between modulators predicted by MINDy of the same TF, and are supported by physical interaction evidence). Depending on the source of evidence, these interactions can be either un-directed (supported by known PPIs), or directed (supported by NetworKIN, i.e. kinase substrate). The inset figure shows the degree distribution of this network, with a linear fitting in the log-log space indicating a scale-free topology. 
Signalome-transfactome interaction network
Discussion
In this manuscript we have provided both computational and experimental evidence suggesting that the MINDy algorithm can be effectively used to map physical and pathway-mediated post-translational interactions between signaling proteins and transcription factors, using only large GEP datasets. Due to lack of appropriate high-throughput technologies, such as microarray expression profiles and ChIP-Chip/Seq assays, dissection of post-translational interactions is lagging significantly behind that of their transcriptional counterpart. As a result, algorithms providing high-accuracy, cell-context specific hypotheses for biochemical validation may significantly improve our ability to elucidate posttranslational processes and their effect on transcriptional networks. Specifically, we have shown that MINDy predictions are highly enriched in experimentally validated interactions and that silencing the most pleiotropic modulator, STK38, produces expression profiles that are highly consistent with the inferred STK38 modulon and regulon.
Such a network topology can be interrogated to address specific biological questions, such as Lastly, another insight that can be gleaned from the signalome-transfactome network reconstructed by MINDy is the specificity of the signaling genes in terms of their ability to regulate the transcriptional response of a cell. In Table 2 shown earlier, signaling genes on columns to the left are more pleiotropic, whereas those to the right are more specific, with respect to the number of TFs (i.e. distinct transcriptional programs) they control. Similarly, TFs on top rows are controlled by broader signaling pathways than those on the bottom rows. Since signaling proteins are often selected as drug target (e.g. by small molecule compound), these results can provide guidance to the selection of intervention point that has the least side effect. Specifically, one may want to target a kinase that is very specific, so that it causes less cross-talk with other transcriptional programs not intended to be affected by the drug molecule.
Methods
Gene expression profile dataset
254 GEP were generated using the Affymetrix HG-U95Av2 GeneChip® System (~12,600 probe sets) 
MINDy Analysis
Given a triplet ( shRNA or non-target control shRNA. Transduction was performed by centrifugation at 450xg for 2h
with supernatants supplemented with 8 μg/ml polybrene. Total RNA was extracted 60h after transduction and prepared for gene expression profiling according to Affymetrix's protocol.
Signalome clustering
Signaling proteins are clustered based on the similarity of their modulon inferred by MINDy.
Specifically, each signaling protein is associated with a vector { } 1 2 , ,..., 
